strong price
report strong result share gain fuel solid
organ sale growth gm upsid announc forward
price enabl compani clearli post
ep growth least in-lin lt hsd algorithm
robust organ sale price horizon report strong
organ sale growth world-wide consum volum
price/mix consensu guidanc
aid less coupon prior year period top-line gm upsid
drove profit upsid vs consensu quarter addit
announc would increas list price hsd across us
portfolio price announc like includ cat
litter well waterpik off-set trade issu organ sale growth
guidanc approxim look conserv us impli bp
sequenti deceler vs bp two-year averag basi given
waterpik grow around estim full quarter waterpik
contribut bp although note expect lower promot
may drive sequenti top-line deceler
growth seem pick modestli growth
categori grow
power brand gain market share us laundri continu
sourc strength arm hammer liquid laundri
versu categori growth arm hammer unit dose versu
categori growth promot environ continu becom
ration coupon bp y-o-i coupon
bp xtra brand appear stabil market share deep valu
segment bp quarter oxiclean market share
oscil promot consum intern organ sale
growth broad base strength driven femfresh batist
vitafus export market batist vitafus cat litter canada
laundri oral care bake soda mexico continu invest long-
term growth consum intern evergreen target sign
household person unit state america
unless otherwis note metric base modelwar
consensu data provid thomson reuter estim
seek busi
compani cover morgan stanley research
result investor awar firm may
conflict interest could affect object
morgan stanley research investor consid
morgan stanley research singl factor make
invest decis
analyst certif import disclosur
refer disclosur section locat end
exclus distribut agreement shanghai jahwa track record
partner sc johnson kao previous bake soda toothpast dri
shampoo feminin hygien mainland china follow recent
invest includ southeast asian distribut agreement dksh
announc new subsidiari germani announc
recent open export offic panama singapor announc
specialti product organ result continu limit
low milk price well trade tension mexico import us chees
china import us whey
number ep cent consensu
mse cent guidanc driven profit
beat vs consensu revenu consensu organ sale
strong difficult environ consensu chd
guidanc gross margin came bp consensu bp y-o-
higher commod transport cost offset
favor price volum drive gross profit upsid lower oper
expens augment gross margin upsid slightli lower vs model
 bp y-o-i vs bp estim bp y-o-i sg decreas
versu guidanc drove cent ep upsid versu model
divis consum domest organ sale higher volum
posit price/mix ii consum organ sale
increas higher volum off-set price/mix iii
spd organ sale volum lower demand dairi
industri low milk price partial off-set price
organ sale oper guidanc rais
reinvest upsid narrow ep guidanc vs
prior slightli consensu mse report sale
growth expect exceed unchang organ sale vs
prior view guidanc conserv typic expect
gross margin declin bp y-o-i unchang market
sale expect exceed vs approxim prior higher
market spend vs previou outlook expect cash
oper exceed vs exceed prior call lower
tax rate guidanc prior regard guid
organ sale growth report sale growth ep
consensu mse although tend conserv
next quarter guidanc beaten next quarter ep guidanc
everi quarter sinc matt farrel began tenur ceo
rais ep estim net post ep estim rise cent
guidanc ep reflect
margin benefit announc price increas price target
prior reflect ep upsid impli ev/ebitda versu
prior remain uw post solid believ solid execut
reflect price-to-earnings premium vs hpc peer particularli
deriv base case scenario
topline/gross margin upsid rebound laundri result drive bp
top-line upsid cost effici weaker expect commod inflat
drive increment basi point gross margin upsid bp
price upsid appli multipl deviat last averag
bull case ep
slow organ growth deliv average org sale growth
long-term target appli price-to-earnings base
case ep line last averag
secular us slowdown worsen revenu growth forecast
due competit price pressur us volum downsid spur
reinvest compress valuat bear case ep
slightli peak trough multipl compress food peer
exhibit bear bull us environ risk laundri price
us skew skew lower growth
competit us market limit lt ep
growth although near-term us price
pick
consolid halo valuat
overdon main reason low
core sg compar peer leav less
room synergi busi
make difficult manag
premium peer limit roic/ep accret
excel manag team
alreadi manag busi well
like less interest mani potenti
acquir view
stretch valuat chd valuat
ep look high us given
limit growth limit strateg potenti
risk achiev price
product higher expect potenti
accret acquisit consolid
us promot intens key
categori ramp us volum downsid
commod inflat execut risk
sale
sale
sale bp chang
sale
sale bp chang
sale
sale bp chang
equiti earn affili
incom minor interest tax
equiti invest affili
account payabl accru expens
postretir postemploy benefit
depreci amort
equiti earn affili
chang a/l
increas liabil
provid oper
flow invest activ
acquisit net
purchas new product line
addit ppe
invest distribut affili
proce sale fix asset
use invest activ
flow financ activit
purchas treasuri stock
proce exercis stock option etc
use financ activ
exchang rate effect
net increas decreas equiv
equiv beg
equiv end
